DOMS Industries (DOMS) Q3 25/26 earnings summary

Executive summary

• Q3 and nine-month FY26 saw strong year-over-year growth, driven by robust domestic demand, innovation-led product launches, and expanding export markets.

• Product portfolio diversification, new launches, and a 50/50 JV with Seven SpA to target premium backpacks and bags segment were announced.

• Capacity expansion included acquisition of land in Jammu, ongoing construction of a major facility in Gujarat, and increased pen manufacturing.

• Strategic acquisitions included stakes in Uniclan Healthcare, SKIDO Industries, Super Treads Pvt. Ltd., and increased stake in Pioneer Stationery.

• Board approved ESOP allotments and incorporation of DOMS Foundation for CSR initiatives.

Financial highlights

• Q3 FY26 consolidated operating revenue: ₹592.2 crore, up 18.2% year-over-year; 9M FY26 revenue: ₹1,722.4 crore, up 22.7%.

• Q3 consolidated EBITDA: ₹103.4 crore (17.5% margin), up 17.7% year-over-year; Q3 PAT: ₹61.4 crore (10.4% margin), up 13.1%.

• Standalone Q3 FY26 revenue: ₹51,113.84 lakhs; net profit: ₹5,405.11 lakhs; EPS: ₹8.93.

• Q3 gross profit margin: 44.2%; 9M FY26 EBITDA margin: 17.5%; PAT margin: 10.5%.

• Nine-month CapEx reached ₹230 crore; full-year CapEx expected to exceed ₹250 crore.

Outlook and guidance

• FY26 revenue growth expected at the upper end of 18%-20% guidance, with similar growth targeted for FY27.

• Commercial operations at the new 44-acre Umbergaon facility expected to commence in Q2FY27.

• FY27 CapEx planned at ₹225-250 crore, with phased capacity additions supporting growth.

• Joint venture with Seven SpA to be completed by June 30, 2026, targeting new product lines and global supply.

• Continued focus on expanding product portfolio and leveraging recent acquisitions.